Susan Mary Cramp

This inventor holds 15 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 11 EPO patents. Top assignees: Zafgen, Inc., Helperby Therapeutics Limited. Active years: 2014-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Susan Mary Cramp. Retrieved from https://idiyas.com/inventor/susan-mary-cramp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 3)

CIPO Patents = 2

EPO Patents = 11 (Patent Applications = 11)

Average Co-Inventor Count = 4.1

ph-index = 5

Forward Citations = 80(Granted Patents)

Company Filing History:

Helperby Therapeutics Limited

patents

Years Active: 2014-2019

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10174009 - Tricyclic sulphonamide compounds and methods of making and using same (2019-01-08),

2. 9868717 - Tricyclic sulphonamide compounds and methods of making and using same (2018-01-16),

3. 9839623 - Tricyclic compounds and methods of making and using same (2017-12-12),

4. 9617237 - Partially saturated tricyclic compounds and methods of making and using same (2017-04-11),

5. 9561230 - Aryl-substituted tricyclic sulfonamides as methionyl aminopeptidase 2 modulators (2017-02-07),

6. 9440943 - Tricyclic sulfone compounds and methods of making and using same (2016-09-13),

7. 9359369 - Tricyclic sulfonamide compounds and methods of making and using same (2016-06-07),

8. 9321740 - Tetrazole compounds and methods of making and using same (2016-04-26),

9. 9290472 - Partially saturated tricyclic compounds and methods of making and using same (2016-03-22),

10. 9266896 - Tricyclic compounds and methods of making and using same (2016-02-23),

11. 9242997 - Tricyclic pyrazole sulphonamide compunds and methods of making and using same (2016-01-26),

12. 9221787 - Sulphonamine compounds and methods of making and using same (2015-12-29),

13. 9187494 - Aryl-substituted tricyclic sulfonamides as methionyl aminopeptidase 2 modulators (2015-11-17),

14. 9067905 - Sulphone compounds and methods of making and using same (2015-06-30),

15. 8759348 - Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms (2014-06-24),

Title: **The Innovative Journey of Susan Mary Cramp**

Introduction

Susan Mary Cramp, a prominent inventor based in Harlow, GB, has made significant contributions to the field of pharmaceuticals with an impressive portfolio of 15 patents. Her work primarily focuses on tricyclic sulphamide compounds, which have potential applications in treating various medical disorders.

Latest Patents

Among her latest inventions, Cramp has developed tricyclic sulphonamide compounds, alongside methods for their production and use. This innovative work provides pharmaceutical compositions aimed at treating medical conditions such as obesity. The compounds demonstrate promising activity against methionyl aminopeptidase 2, potentially paving the way for new therapeutic avenues.

Career Highlights

Throughout her extensive career, Susan has collaborated with notable companies in the pharmaceutical sector, including Zafgen, Inc. and Helperby Therapeutics Limited. Her groundbreaking research and invention in the pharmaceutical field have established her as a leading figure in innovation, particularly in the area of drug development.

Collaborations

Cramp has worked alongside respected colleagues such as Thomas David Pallin and Hazel Joan Dyke. Their collaborative efforts have contributed to advancements in her fields of expertise, further enhancing the impact of her innovations.

Conclusion

With a remarkable track record of patents and a dedicated career in pharmaceutical innovation, Susan Mary Cramp stands out as a notable inventor whose work holds the potential to revolutionize treatment methodologies. Her commitment to advancing medical science is evident through her ongoing contributions and collaborations in the field.

Profile summary based on public USPTO records.